NASDAQ: ENTO
Entero Therapeutics Inc Stock Ownership - Who owns Entero Therapeutics?

Insider buying vs selling

Have Entero Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sarah RomanoChief Financial Officer2025-01-06727$0.64
$465.28Sell
Sarah RomanoChief Financial Officer2024-10-09476$0.45
$212.30Sell

1 of 1

ENTO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ENTO insiders and whales buy or sell their stock.

ENTO Shareholders

What type of owners hold Entero Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Edmund Burke Ross Jr.63.80%3,040,555$1.48MInsider
Pelican Partners LLC34.16%1,627,796$792.74kInsider
Johan M. Spoor8.78%418,319$203.72kInsider
Charles J. Casamento2.87%136,935$66.69kInsider
David Andrew Hoffman1.90%90,778$44.21kInsider
Vern Lee Schramm1.90%90,498$44.07kInsider
Maged Shenouda1.31%62,500$30.44kInsider
Ubs Group Ag1.22%57,975$28.23kInstitution
Geode Capital Management LLC0.77%36,560$17.80kInstitution
James Sapirstein0.75%35,816$17.44kInsider

1 of 3

ENTO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ENTO2.44%97.56%Net Selling
ALZN0.18%99.82%Net BuyingNet Selling
ONCO3.96%96.04%
PTIX57.35%7.78%
ADTX1.13%98.87%Net Selling

Entero Therapeutics Stock Ownership FAQ

Who owns Entero Therapeutics?

Entero Therapeutics (NASDAQ: ENTO) is owned by 2.97% institutional shareholders, 118.59% Entero Therapeutics insiders, and 0.00% retail investors. Edmund Burke Ross Jr. is the largest individual Entero Therapeutics shareholder, owning 3.04M shares representing 63.80% of the company. Edmund Burke Ross Jr.'s Entero Therapeutics shares are currently valued at $1.49M.

If you're new to stock investing, here's how to buy Entero Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.